skip to main content
Idioma:
Refinado por: Nome da Publicação: Bmc Pharmacology remover assunto: Mice remover assunto: Mice, Nude remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene
Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene
Material Type:
Artigo 		Adicionar ao Meu Espaço

Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene

Galmarini, Carlos María ; Clarke, Marilyn L ; Jordheim, Lars ; Santos, Cheryl L ; Cros, Emeline ; Mackey, John R ; Dumontet, Charles

BMC pharmacology, 2004-05, Vol.4 (1), p.8-8 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
2
Impact of imatinib on the pharmacokinetics and in vivo efficacy of etoposide and/or ifosfamide
Impact of imatinib on the pharmacokinetics and in vivo efficacy of etoposide and/or ifosfamide
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of imatinib on the pharmacokinetics and in vivo efficacy of etoposide and/or ifosfamide

Rezaï, Keyvan ; Lokiec, François ; Grandjean, Isabelle ; Weill, Sophie ; de Cremoux, Patricia ; Bordier, Vincent ; Ekue, Richard ; Garcia, Mickael ; Poupon, Marie-France ; Decaudin, Didier

BMC pharmacology, 2007-10, Vol.7 (13), p.13-13, Article 13 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
3
Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models
Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models

Lee, Nancy ; Woodrum, Chelsey L ; Nobil, Alison M ; Rauktys, Aubrey E ; Messina, Michael P ; Dabora, Sandra L

BMC pharmacology, 2009-04, Vol.9 (1), p.8-8, Article 8 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
Chlorin e6 - polyvinylpyrrolidone mediated photosensitization is effective against human non-small cell lung carcinoma compared to small cell lung carcinoma xenografts
Chlorin e6 - polyvinylpyrrolidone mediated photosensitization is effective against human non-small cell lung carcinoma compared to small cell lung carcinoma xenografts
Material Type:
Artigo 		Adicionar ao Meu Espaço

Chlorin e6 - polyvinylpyrrolidone mediated photosensitization is effective against human non-small cell lung carcinoma compared to small cell lung carcinoma xenografts

Chin, William W L ; Heng, Paul W S ; Olivo, Malini

BMC pharmacology, 2007-12, Vol.7 (15), p.15-15, Article 15 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
5
Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779
Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779

Messina, Michael P ; Rauktys, Aubrey ; Lee, Laifong ; Dabora, Sandra L

BMC pharmacology, 2007-11, Vol.7 (1), p.14-14, Article 14 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.